Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Direct integrin alphavbeta6-ERK binding: implications for tumour growth.

Nuzhat Ahmed1, Jun Niu, Douglas J Dorahy

  • 1Gynaecological Cancer Research Centre, The Royal Women's Hospital, Melbourne and University of Melbourne, Melbourne, Australia.

Oncogene
|February 22, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion.

Journal of biomedical science·2026
Same author

Psoriasis as a systemic inflammatory disease: an immune set-point framework for comorbidities and relapse.

Frontiers in immunology·2026
Same author

Targeted next-generation sequencing for microbial and clinical diagnosis: a prospective controlled comparison between sputum and bronchoalveolar lavage fluid in patients with community-acquired pneumonia.

BMC infectious diseases·2026
Same author

Treatment of Kimura disease with dupilumab: a case report and literature review.

Frontiers in immunology·2026
Same author

MicroRNA-488-3p-loaded engineered exosomes inhibit proliferation, migration and invasion of hepatocellular carcinoma by targeting SEC61G.

PloS one·2026
Same author

TIPE2 serves as a favorable prognostic biomarker and suppresses cholangiocarcinoma progression by targeting RAC1-mediated integrin αvβ6 trafficking.

Scientific reports·2026

Blocking the mitogen-activated protein (MAP) kinase pathway and integrin alphavbeta6 inhibits colon cancer growth. This study reveals a direct link between ERK2 and integrin alphavbeta6, offering a new therapeutic target for colon cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The mitogen-activated protein (MAP) kinase pathway is crucial for cell growth and is often dysregulated in cancer.
  • Integrins are cell adhesion molecules that play roles in cell signaling and cancer progression.
  • Integrin alphavbeta6 is implicated in promoting tumor growth in various cancers, including colon cancer.

Purpose of the Study:

  • To investigate the direct link between ERK2, a key component of the MAP kinase pathway, and the integrin alphavbeta6 in colon cancer cells.
  • To determine the functional significance of the interaction between ERK2 and integrin alphavbeta6 in colon cancer growth.
  • To explore the potential of targeting this interaction as a therapeutic strategy for colon cancer.

Main Methods:

Related Experiment Videos

  • Utilized colon cancer cell lines with varying expression levels of integrin alphavbeta6.
  • Employed co-immunoprecipitation assays to detect physical interactions between ERK2 and integrin subunits.
  • Performed in vivo tumor growth studies in mouse models to assess the impact of modulating the integrin-ERK2 interaction.
  • Conducted experiments involving deletion of the ERK2 binding site on the beta6 cytoplasmic domain.

    • Main Results:

    • Demonstrated a direct physical association between ERK2 and the beta6 integrin subunit in alphavbeta6-expressing colon cancer cells.
    • Showed that down-regulation of beta6 integrin subunit expression inhibits tumor growth in vivo and reduces MAP kinase activity.
    • Found that deletion of the ERK2 binding site on the beta6 cytoplasmic domain inhibits tumor growth and alters ERK subunit association.
    • Established that ERK2 bound to beta6 accounts for the increase in cytosolic MAP kinase activity upon epidermal growth factor stimulation.

    Conclusions:

    • The physical interaction between integrin alphavbeta6 and ERK2 represents a novel mechanism of integrin-mediated signaling in colon cancer.
    • Targeting the alphavbeta6-ERK2 interaction can suppress colon cancer growth, highlighting its potential as a therapeutic target.
    • This discovery provides a new paradigm for understanding integrin function in cancer and opens avenues for drug development.